{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:42:29Z","timestamp":1788349349569,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.hoc.2021.12.002","type":"journal-article","created":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T00:34:39Z","timestamp":1646958879000},"page":"283-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Red Cell Antigens and Antibodies"],"prefix":"10.1016","volume":"36","author":[{"given":"Christine","family":"Lomas-Francis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie M.","family":"Westhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2021.12.002_bib1","series-title":"Immune hemolytic anemias","author":"Garratty","year":"2004"},{"key":"10.1016\/j.hoc.2021.12.002_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.21307\/immunohematology-2019-403","article-title":"Autoimmune hemolytic anemia and a further example of autoanti-Kpb","volume":"21","author":"Lee","year":"2005","journal-title":"Immunohematology"},{"key":"10.1016\/j.hoc.2021.12.002_bib3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2141.1987.00199.x-i1","article-title":"Acquired loss of red cell Kell antigens","volume":"65","author":"Vengelen-Tyler","year":"1987","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2021.12.002_bib4","first-page":"634","article-title":"Severe warm autoimmune haemolytic anaemia due to anti-Jk(a) autoantibody associated with Parvovirus B19 infection in a child","volume":"11","author":"Giovannetti","year":"2013","journal-title":"Blood Transfus"},{"key":"10.1016\/j.hoc.2021.12.002_bib5","series-title":"AABB technical manual","year":"2020"},{"key":"10.1016\/j.hoc.2021.12.002_bib6","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1172\/JCI116376","article-title":"Erythrocyte membrane proteins reactive with human (warm-reacting) anti-red cell autoantibodies","volume":"91","author":"Leddy","year":"1993","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.hoc.2021.12.002_bib7","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/trf.14363","article-title":"Acute autoimmune hemolytic anemia due to anti-En(a) autoantibody successfully treated with rituximab","volume":"58","author":"Nedelcu","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.hoc.2021.12.002_bib8","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1537-2995.2009.02445.x","article-title":"Life-threatening hemolytic anemia due to an autoanti-Pr cold agglutinin: evidence that glycophorin A antibodies may induce lipid bilayer exposure and cation permeability independent of agglutination","volume":"50","author":"Brain","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.hoc.2021.12.002_bib9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/trf.13903","article-title":"the Biomedical Excellence for Safer Transfusion C. Warm-reactive (immunoglobulin G) autoantibodies and laboratory testing best practices: review of the literature and survey of current practice","volume":"57","author":"Ziman","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.hoc.2021.12.002_bib10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/vox.12914","article-title":"Red-blood-cell alloimmunization and prophylactic antigen matching for transfusion in patients with warm autoantibodies","volume":"115","author":"Delaney","year":"2020","journal-title":"Vox Sang"},{"key":"10.1016\/j.hoc.2021.12.002_bib11","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1046\/j.1537-2995.2003.00583.x","article-title":"\u201cLeast incompatible\u201d units for transfusion in autoimmune hemolytic anemia: should we eliminate this meaningless term? A commentary for clinicians and transfusion medicine professionals","volume":"43","author":"Petz","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.hoc.2021.12.002_bib12","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1182\/blood-2018-11-833954","article-title":"Blood group genotyping","volume":"133","author":"Westhoff","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2021.12.002_bib13","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1046\/j.1537-2995.2002.00234.x","article-title":"Prophylactic antigen-matched donor blood for patients with warm autoantibodies: an algorithm for transfusion management","volume":"42","author":"Shirey","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.hoc.2021.12.002_bib14","first-page":"265","article-title":"Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectives","volume":"10","author":"Barcellini","year":"2019","journal-title":"J\u00a0Blood Med"},{"key":"10.1016\/j.hoc.2021.12.002_bib15","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1056\/NEJMra1703481","article-title":"Adverse Events Associated with Immune Checkpoint Blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hoc.2021.12.002_bib16","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1537-2995.2004.00414.x","article-title":"Nonhemolytic passenger lymphocyte syndrome with anti-Jk after allogeneic peripheral blood progenitor cell transplantation","volume":"44","author":"Leo","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.hoc.2021.12.002_bib17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1537-2995.2012.03942.x","article-title":"Hemolytic anemia due to passenger lymphocyte syndrome in solid malignancy patients treated with allogeneic natural killer cell products","volume":"53","author":"Skeate","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.hoc.2021.12.002_bib18","first-page":"10","article-title":"Difficult Cases of Paroxysmal Nocturnal Hemoglobinuria: Diagnosis and Therapeutic Novelties","author":"Fattizzo","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.hoc.2021.12.002_bib19","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.bbmt.2017.12.782","article-title":"Risk Factors, Treatment, and Immune Dysregulation in Autoimmune Cytopenia after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients","volume":"24","author":"Kruizinga","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.hoc.2021.12.002_bib20","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/1759-7714.13281","article-title":"Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor related hematological adverse events","volume":"11","author":"Zhuang","year":"2020","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.hoc.2021.12.002_bib21","doi-asserted-by":"crossref","first-page":"946","DOI":"10.3389\/fimmu.2020.00946","article-title":"The Changing Landscape of Autoimmune Hemolytic Anemia","volume":"11","author":"Barcellini","year":"2020","journal-title":"Front Immunol"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858821001659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858821001659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:16:48Z","timestamp":1760185008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858821001659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0889858821001659"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2021.12.002","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Red Cell Antigens and Antibodies","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2021.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}